Daily Judi: Thursday, November 3, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Matthew Herper, at STAT, details how in the same way that the last century was marked by advancements in physics, this century is biological.
GSK reached its goals on two phase 3 trials for a urinary tract infection treatment, evaluating the antibody gepotidacin, and is expected to seek FDA approval in the new year. (Fierce Biotech)
Lebanon is experiencing a severe cholera outbreak. To battle the disease, vaccines were donated by Paris-based pharmaceutical company Sanofi. (Reuters)
The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team AG Mednet will be there!
Our Culture
“We create a template so we can pull back the timelines and eliminate concerns around quality and risk—because everything’s already validated in the design. Then we can work faster with no risk to quality.”
–Jamie, Trial Delivery
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.